|
|
|
Peking University Health Science Center , Beijing, China
Dec 13 2011 8:00AM - Dec 14 2011 5:00PM
With the continually increase of clinical studies in China, ethical considerations and good practices in clinical research and studies have received more attention by regulators, investigators/practitioners, and study sponsors. Good ethics practice plays an important role in both protecting and benefiting patients through medical and pharmaceutical science and technology development. This two-day training course is an interactive forum that provides in-depth knowledge, international and China regulatory guidelines, and practical solutions to assist participants to gain a better understanding of the ethical requirement and to implement best ethics practices in clinical research. The course is designed by subject matter experts with examples from real-life experience. The instructors will compare Chinese requirements and ICH/European/US requirements with special focus on ethical review, the informed consent process, and risk management. Event Code: 11980
|
|
|
|
|
|
Organized by:
|
|
DIA China |
|
Invited Speakers:
|
|
See website for speaker information
|
|
|
|
|
|
Deadline for Abstracts:
|
|
Call contact
|
|
|
|
|
|
Registration:
|
|
Gateway Plaza A, Room 1155, 18 XiaGuangLi, North Road Third Ring| Chaoyang District, Beijing, 100027, China Tel: +86-10-59231222 Fax: +86-10-59231180
|
|
E-mail:
|
|
fei.XIE@diachina.org
|
|
|
|
|
|
|
|